COMPARISON WITH ERADICATION RATES OF MOXIFLOXACIN CONTAINING TRIPLE THERAPY AS SECOND LINE TREATMENT FOR HELICOBACTER PYLORI INFECTION ACCORDING TO FIRST LINE REGIMEN

被引：0
|
作者：
Kang, K. [1 ]
Lee, D. [1 ]
Oh, D. [1 ]
Kim, N. [1 ]
Park, Y. [1 ]
Shin, C. [1 ]
Yoon, H. [1 ]
Jung, H. [2 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea
来源：
HELICOBACTER | 2013年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [1] Comparison with eradication rates of moxifloxacin therapy as second line according to first regimen
    Kang, Kyu Keun
    Lee, Dong Ho
    Oh, Dong Hyun
    Kim, Nayoung
    Park, Young Soo
    Shin, Cheol Min
    Yoon, Hyuk
    Hwang, Jin Hyeok
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 327 - 327
  • [2] THE EFFECT OF MOXIFLOXACIN CONTAINING TRIPLE THERAPY AS SECOND-LINE TREATMENT FOR HELICOBACTER PYLORI ERADICATION INFECTION
    Hwang, J.
    Lee, D.
    Yoon, K.
    Lee, H.
    Jeong, Y.
    Kwon, Y.
    Lee, A.
    Yoon, H.
    Shin, C.
    Park, Y.
    Kim, N.
    Seol, S.
    Jung, H.
    [J]. HELICOBACTER, 2014, 19 : 139 - 139
  • [3] The Eradication Efficacies of Hybrid Therapy As First-Line Regimen Plus Levofloxacin-Containing Triple Therapy As Second-Line Regimen for Helicobacter pylori Infection
    Song, Zhiqiang
    Zhou, Liya
    Zhang, Jianzhong
    He, Lihua
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S421 - S421
  • [4] THE TREND OF ERADICATION RATES OF FIRST LINE THERAPY AND SECOND LINE QUADRUPLE THERAPY CONTAINING METRONIDAZOLE FOR HELICOBACTER PYLORI INFECTION IN KOREA
    Song, J.
    Chung, I.
    [J]. HELICOBACTER, 2011, 16 : 137 - 137
  • [5] Comparison of efficacy of bismuth containing quintet therapy and moxifloxacin-based sequential therapy as first-line eradication regimen for Helicobacter Pylori infection
    Hwang, J.
    Lee, D.
    Yoon, H.
    Shin, C.
    Park, Y.
    Kim, N.
    Seol, S.
    Jung, H.
    [J]. HELICOBACTER, 2016, 21 : 144 - 144
  • [6] Moxifloxacin-Containing Triple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate
    Yoon, Hyuk
    Kim, Nayoung
    Lee, Byoung Hwan
    Hwang, Tae Jun
    Lee, Dong Ho
    Park, Young Soo
    Nam, Ryoung Hee
    Jung, Hyun Chae
    Song, In Sung
    [J]. HELICOBACTER, 2009, 14 (05) : 77 - 85
  • [7] Metaanalysis: Moxifloxacin Triple Therapy for First-Line and Rescue Treatment of Helicobacter pylori Infection
    Miehlke, Stephan
    Ruecker, Gerta
    Krasz, Susanne
    Morgner, Andrea
    Labenz, Joachim
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S483 - S483
  • [8] Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection
    Cheon, JH
    Kim, N
    Lee, DH
    Kim, JM
    Kim, JS
    Jung, HC
    Song, IS
    [J]. HELICOBACTER, 2006, 11 (01) : 46 - 51
  • [9] Efficacy of Moxifloxacin-Based Sequential Therapy and Hybrid Therapy as First-Line Eradication Regimen for Helicobacter pylori Infection
    Lee, Dong Ho
    Hwang, Jae Jin
    [J]. DIGESTION, 2017, 95 (01) : 94 - 95
  • [10] Moxifloxacin Containing Triple Therapy vs. Moxifloxacin and Bismuth-Containing Quadruple Therapy for First-Line Treatment of Helicobacter pylori (H. pylori) Infection
    Ciccaglione, Antonio Francesco
    Cellini, Luigina
    Grossi, Laurino
    Di Tullio, Ada Maria
    Pagliaro, Mauro
    Tavani, Roberta
    Cocciolillo, Sila
    Marzio, Leonardo
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S482 - S482
12345